- Home
- NBR vs EBS Comparison
NBR vs EBS Comparison
Compare NBR & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBR
- EBS
- Stock Information
- Founded
- NBR 1952
- EBS 1998
- Country
- NBR Bermuda
- EBS United States
- Employees
- NBR N/A
- EBS N/A
- Industry
- NBR Oil & Gas Production
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- NBR Energy
- EBS Health Care
- Exchange
- NBR Nasdaq
- EBS Nasdaq
- Market Cap
- NBR 417.7M
- EBS 353.9M
- IPO Year
- NBR N/A
- EBS 2006
- Fundamental
- Price
- NBR $30.31
- EBS $6.99
- Analyst Decision
- NBR Hold
- EBS Strong Buy
- Analyst Count
- NBR 8
- EBS 3
- Target Price
- NBR $44.50
- EBS $14.33
- AVG Volume (30 Days)
- NBR 545.2K
- EBS 1.4M
- Earning Date
- NBR 07-29-2025
- EBS 08-05-2025
- Dividend Yield
- NBR N/A
- EBS N/A
- EPS Growth
- NBR N/A
- EBS N/A
- EPS
- NBR N/A
- EBS N/A
- Revenue
- NBR $2,932,608,000.00
- EBS $965,400,000.00
- Revenue This Year
- NBR $13.65
- EBS N/A
- Revenue Next Year
- NBR $5.53
- EBS $18.88
- P/E Ratio
- NBR N/A
- EBS N/A
- Revenue Growth
- NBR N/A
- EBS N/A
- 52 Week Low
- NBR $23.27
- EBS $4.02
- 52 Week High
- NBR $105.96
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- NBR 53.01
- EBS 59.80
- Support Level
- NBR $27.33
- EBS $6.21
- Resistance Level
- NBR $31.73
- EBS $6.95
- Average True Range (ATR)
- NBR 2.10
- EBS 0.39
- MACD
- NBR -0.17
- EBS 0.03
- Stochastic Oscillator
- NBR 38.57
- EBS 76.00
About NBR Nabors Industries Ltd.
Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and technologies. The company has four reportable segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.